Advertisement

Characterization of Extracellular HSV-1 Virions by Proteomics

  • Roger LippéEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 2060)

Abstract

The analysis of HSV-1 mature extracellular virions by proteomics requires highly enriched samples to limit false-positives and favor the detection of true components. The protocol described below involves the removal of highly contaminating serum proteins and purification of the virions by a series of differential and density centrifugation steps. In addition, L-particles, which are viral particles devoid of a genome and capsid but present in the extracellular milieu, are depleted on Ficoll 400 gradients. As previously reported, the resulting viral particles are free of most contaminants and suitable for mass spectrometry.

Key words

HSV-1 Herpes Simplex Proteomics Mass spectrometry Protein composition Virions Viral particle 

Notes

Acknowledgments

This work was supported by grants from the Canadian Institutes of Health Research (MOP 82921 and MOP 258030). Special thanks to Kerstin Radtke and Nabil El Bilali for proofreading and Christina Bell for the mass spectrometry protocols.

References

  1. 1.
    Viswanathan K, Fruh K (2007) Viral proteomics: global evaluation of viruses and their interaction with the host. Expert Rev Proteomics 4:815–829CrossRefGoogle Scholar
  2. 2.
    Munday DC, Surtees R, Emmott E et al (2012) Using SILAC and quantitative proteomics to investigate the interactions between viral and host proteomes. ProteomicsGoogle Scholar
  3. 3.
    Ma-Lauer Y, Lei J, Hilgenfeld R et al (2012) Virus-host interactomes–antiviral drug discovery. Curr Opin Virol 2:614–621CrossRefGoogle Scholar
  4. 4.
    Zhou S, Liu R, Zhao X et al (2011) Viral proteomics: the emerging cutting-edge of virus research. Sci China Life Sci 54:502–512CrossRefGoogle Scholar
  5. 5.
    Leroy B, Gillet L, Vanderplasschen A et al (2016) Structural proteomics of Herpesviruses. Viruses 8Google Scholar
  6. 6.
    Greco TM, Cristea IM (2017) Proteomics tracing the footsteps of infectious disease. Mol Cell Proteomics 16:S5–S14CrossRefGoogle Scholar
  7. 7.
    Lippé R (2012) Deciphering novel host–herpesvirus interactions by virion proteomics. Front Microbio 3:1–14CrossRefGoogle Scholar
  8. 8.
    Malouli D, Nakayasu ES, Viswanathan K et al (2012) Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1. J Virol 86:8959–8973CrossRefGoogle Scholar
  9. 9.
    Engel EA, Song R, Koyuncu OO et al (2015) Investigating the biology of alpha herpesviruses with MS-based proteomics. Proteomics 15:1943–1956CrossRefGoogle Scholar
  10. 10.
    Loret S, Guay G, Lippé R (2008) Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J Virol 82:8605–8618CrossRefGoogle Scholar
  11. 11.
    Stegen C, Yakova Y, Henaff D et al (2013) Analysis of virion-incorporated host proteins required for herpes simplex virus type 1 infection through a RNA interference screen. PLoS One 8:e53276CrossRefGoogle Scholar
  12. 12.
    Khadivjam B, Stegen C, Hogue-Racine MA et al (2017) The ATP-dependent RNA helicase DDX3X modulates herpes simplex virus type 1 gene expression. J Virol 91:e02411–e02416CrossRefGoogle Scholar
  13. 13.
    Bell C, Desjardins M, Thibault P et al (2013) Proteomics analysis of herpes simplex virus type 1-infected cells reveals dynamic changes of viral protein expression, ubiquitylation and phosphorylation. J Proteome Res 12:1820–1829CrossRefGoogle Scholar
  14. 14.
    Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367–1372CrossRefGoogle Scholar
  15. 15.
    Cox J, Matic I, Hilger M et al (2009) A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat Protoc 4:698–705CrossRefGoogle Scholar
  16. 16.
    Szilagyi JF, Cunningham C (1991) Identification and characterization of a novel non-infectious herpes simplex virus-related particle. J Gen Virol 72:661–668CrossRefGoogle Scholar
  17. 17.
    Chevallet M, Luche S, Rabilloud T (2006) Silver staining of proteins in polyacrylamide gels. Nat Protoc 1:1852–1858CrossRefGoogle Scholar
  18. 18.
    Gharahdaghi F, Weinberg CR, Meagher DA et al (1999) Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20:601–605CrossRefGoogle Scholar
  19. 19.
    Nikolsky Y, Nikolskaya T, Bugrim A (2005) Biological networks and analysis of experimental data in drug discovery. Drug Discov Today 10:653–662CrossRefGoogle Scholar
  20. 20.
    Kanehisa M, Goto S, Furumichi M et al (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38:D355–D360CrossRefGoogle Scholar
  21. 21.
    Ashburner M, Ball CA, Blake JA et al (2000) Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 25:25–29CrossRefGoogle Scholar
  22. 22.
    Huang d W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Department of Pathology and Cell BiologyUniversity of MontrealMontrealCanada

Personalised recommendations